Finasteride Cost in Hawaii 2026: Cash Price, Insurance, and Compounded Options

What Is the Cash Price of Finasteride in Hawaii in 2026?

Generic finasteride at Hawaii retail pharmacies costs approximately $12 per month for a 30-tablet supply of the 1 mg dose in 2026. That figure reflects GoodRx-tracked cash prices at major chains including Walgreens, CVS, and Costco locations across Oahu, Maui, and the Big Island. Brand-name Propecia carries a manufacturer list price near $85 per month, but almost no cash-paying patient fills brand-name finasteride when a $12 generic is on the shelf.

The FDA first approved finasteride 1 mg (Propecia) for male androgenetic alopecia (AGA) in 1997, and generic versions have been available in the United States since 2006, which is the primary driver of the price collapse. [1] Finasteride 5 mg (Proscar) for benign prostatic hyperplasia (BPH) has an even longer generic history, and some patients prescribed 5 mg for BPH, or who use a pill-splitter to produce four 1.25 mg doses from one 5 mg tablet, pay as little as $8 to $10 per month at Hawaii pharmacies. Pill-splitting should only be done after a conversation with a prescribing clinician, because tablet coatings and score lines vary by manufacturer.

Hawaii's geography creates a small but real cost premium compared to mainland U.S. averages. Shipping and distribution overhead means island pharmacies may run $1 to $3 higher per fill than, say, a Phoenix Costco. Patients on Oahu generally have access to the most competitive pricing due to pharmacy density; patients on Molokai or Lanai may find it more cost-effective to use a mail-order pharmacy that ships to Hawaii rather than relying on a single local independent pharmacy.

The FDA label for finasteride remains the authoritative source on approved indications, dosing, and contraindications. [2] Patients should confirm any generic they receive is an FDA-approved formulation, not an unregulated supplement marketed as "finasteride."

How Does Finasteride Work and Why Do the Doses Differ?

Finasteride is a 4-azasteroid that selectively inhibits type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is the androgen responsible for both follicle miniaturization in AGA and prostate cell proliferation in BPH. [3] At 1 mg daily, finasteride suppresses scalp DHT by roughly 60%; at 5 mg daily, it suppresses serum DHT by up to 70%. [4]

The 2-year key trial by Kaufman et al. (N=1,553 men with vertex and anterior mid-scalp AGA) demonstrated that 83% of men taking finasteride 1 mg maintained or increased hair count versus baseline, compared with 28% in the placebo group. [5] Hair count increased by a mean of 107 hairs per 1 cm² target area in the finasteride group. That trial established the core efficacy data still cited in the FDA label and still referenced in every major dermatology guideline.

The American Academy of Dermatology (AAD) 2024 guidelines on AGA state: "Finasteride 1 mg daily is a first-line pharmacologic option for men with androgenetic alopecia based on consistent Level I evidence." [6] Consistent evidence across multiple randomized trials supports daily oral use rather than intermittent dosing, because DHT suppression is concentration-dependent and drops off within 48 to 72 hours of a missed dose. [3]

For BPH, the 5 mg dose reduced prostate volume by a mean of 20% at 12 months in the PLESS trial (N=3,040), and reduced the risk of acute urinary retention by 57% over 4 years. [7] Hawaii urologists and primary care clinicians routinely prescribe the 5 mg formulation for symptomatic BPH, and the generic 5 mg tablet is consistently available at Hawaii pharmacies.

Does Hawaii Medicaid (Med-QUEST) Cover Finasteride?

Hawaii Medicaid, administered through the Med-QUEST Division, does not cover finasteride for androgenetic alopecia. Hair loss is classified as a cosmetic condition in the Med-QUEST preferred drug list, and finasteride 1 mg is not included as a covered benefit for that indication. [8]

Coverage for the 5 mg formulation used in BPH is a separate question. Finasteride 5 mg is included on many Medicaid formularies nationally for BPH, and Hawaii Med-QUEST has historically covered alpha-blockers and 5-alpha-reductase inhibitors for symptomatic BPH when documented with appropriate ICD-10 coding (N40.1, BPH with lower urinary tract symptoms). Patients seeking BPH coverage should confirm the current formulary status directly with Med-QUEST or their managed care plan (either AlohaCare, UnitedHealthcare Community Plan, or Ohana Health Plan), as formularies update quarterly. [8]

No prior-authorization pathway exists in Med-QUEST for cosmetic hair-loss treatment with finasteride. A clinician letter of medical necessity will not change that coverage determination because the exclusion is categorical, not case-by-case. Cash-pay generic pricing at $12 per month is low enough that most uninsured or Medicaid-only patients in Hawaii can access finasteride without a coverage appeal.

The HealthRX Hawaii Coverage Decision Framework: If your primary indication is AGA, assume no Medicaid coverage and plan for cash-pay or manufacturer savings card pricing. If your primary indication is BPH with confirmed LUTS, submit a prior-authorization request to your Med-QUEST managed care plan with ICD-10 N40.1 documentation before filling the prescription, because coverage is possible and could reduce your cost to $0 or a nominal copay.

Which Private Insurance Plans Cover Finasteride in Hawaii?

Private insurance coverage for finasteride in Hawaii depends on the indication documented on the prescription and the specific formulary of the plan. Hawaii's major private insurers include HMSA (Hawaii Medical Service Association, the Blue Cross Blue Shield affiliate), Kaiser Permanente Hawaii, Ohana Health Plan commercial products, and UnitedHealthcare.

HMSA's commercial formularies generally cover finasteride 5 mg for BPH on Tier 1 or Tier 2, with copays typically between $5 and $20 per month depending on plan design. Finasteride 1 mg for AGA is typically excluded as a cosmetic benefit under HMSA commercial plans, mirroring the national BCBS pattern. Kaiser Permanente Hawaii operates as a closed-panel HMO; finasteride 5 mg for BPH is covered as a generic on Kaiser's formulary, while the 1 mg AGA formulation requires documentation of medical necessity, which is rarely approved. [9]

Employer-sponsored plans governed by ERISA are not required to follow Hawaii's state insurance mandates, so coverage terms for those plans are set entirely by the employer's plan document. Employees in Hawaii working for large mainland employers may be on an ERISA self-funded plan with a national pharmacy benefit manager (PBM) such as CVS Caremark, Express Scripts, or OptumRx. Those PBMs may or may not cover finasteride 1 mg; the fastest way to check is to call the member services number on the back of the insurance card and ask specifically: "Is finasteride 1 mg covered for androgenetic alopecia on my formulary, and what tier?"

If finasteride 1 mg is not covered under a commercial plan, the cash-pay generic price of $12 per month is frequently lower than the plan's generic copay tier anyway, meaning the insurance card may actually cost more to use than paying out of pocket with a discount card.

Is Compounded Finasteride Legal in Hawaii?

Compounded finasteride is legal in Hawaii when prepared by a licensed 503A pharmacy operating under state pharmacy board oversight and the federal Drug Quality and Security Act (DQSA). [10] A 503A pharmacy compounds for individual patients based on a valid prescriber order; it does not manufacture bulk product for resale. Hawaii's Board of Pharmacy licenses 503A compounding pharmacies and has not issued any state-specific restrictions on compounding finasteride beyond the federal framework.

The FDA has not placed finasteride on its list of drugs withdrawn from the market for safety reasons, nor on the 503A Bulks List of substances that cannot be compounded. [10] That means a licensed Hawaii 503A pharmacy can legally compound finasteride into alternative dosage forms, such as a topical solution, a different oral strength, or a combination formulation with minoxidil or dutasteride, when a prescriber documents clinical rationale for the deviation from commercially available forms.

Compounded finasteride from a Hawaii 503A pharmacy typically costs about $45 per month, which is higher than the $12 cash-pay generic tablet but lower than the $85 brand-name list price. The cost premium over generic reflects the labor and materials of compounding, not superior efficacy. No published randomized trial demonstrates that topical compounded finasteride outperforms oral generic finasteride for AGA, though topical formulations may reduce systemic DHT suppression and theoretically lower the rate of systemic side effects. [11]

Patients should verify that any compounding pharmacy they use in Hawaii holds an active license with the Hawaii Board of Pharmacy and is in good standing with the FDA's MedWatch program. Prescriptions from out-of-state telehealth providers are valid for compounded finasteride in Hawaii as long as the prescriber holds an active Hawaii medical license or a telemedicine registration under Hawaii's telehealth statute (HRS Chapter 453). [12]

Can I Get Finasteride via Telehealth in Hawaii?

Telehealth prescribing of finasteride is fully legal in Hawaii for both AGA and BPH. Hawaii Revised Statutes Chapter 453 permits prescribing via synchronous audio-video telehealth and, under specific conditions, asynchronous store-and-forward platforms, provided the prescriber establishes a valid patient-physician relationship. [12]

That means a patient in Hilo, Kailua-Kona, or Kahului can have a video or asynchronous photo-based consultation with a licensed Hawaii physician or advanced practice registered nurse (APRN), receive a finasteride prescription, and fill it at a local pharmacy or through a mail-order pharmacy without ever setting foot in a clinic. HealthRX's own telehealth platform follows this model; consultations typically take 10 to 20 minutes and include a review of contraindications, a discussion of the sexual side effect profile, and a PSA baseline recommendation for men over 40.

The Endocrine Society's 2023 clinical practice guideline on testosterone and related androgenic therapies notes that 5-alpha-reductase inhibitors should be prescribed only after a thorough discussion of the risk of sexual side effects, including decreased libido (reported in 1.8% of men in key trials), erectile dysfunction (1.3%), and ejaculatory disorder (1.2%), as well as the post-finasteride syndrome debate that remains unresolved in the literature. [13] Telehealth visits in Hawaii must include this informed consent discussion and should document it in the clinical note.

For BPH specifically, the American Urological Association 2023 guideline recommends baseline assessment of International Prostate Symptom Score (IPSS), post-void residual volume, and PSA before initiating a 5-alpha-reductase inhibitor. [14] A telehealth platform that prescribes finasteride 5 mg for BPH without arranging these baseline labs is not meeting the AUA standard of care. Patients should ask telehealth providers whether lab work is included in the workflow before signing up.

What Is the Cheapest Way to Get Finasteride in Hawaii?

The lowest-cost path to finasteride in Hawaii for most patients is a GoodRx or RxSaver coupon applied to a 90-day supply of generic finasteride 1 mg at a high-volume retail pharmacy such as Costco Honolulu or a Walmart pharmacy on Oahu. A 90-day supply at these locations has been documented at $15 to $24 total, which works out to $5 to $8 per month. [15]

Key steps to minimize cost:

1. Get a prescription for a 90-day supply rather than 30 days. Many prescribers default to 30-day supplies, but a 90-day fill reduces per-tablet dispensing overhead and is legal in Hawaii for maintenance medications.
2. Use a free discount card such as GoodRx, RxSaver, or NeedyMeds rather than your insurance card if your plan's generic copay is above $15 per month.
3. Ask the pharmacist to run the price on both finasteride 1 mg and finasteride 5 mg. Some patients prescribed 1 mg for AGA discuss tablet-splitting of the 5 mg generic with their clinician because the 5 mg tablet may be cheaper per milligram. This is a clinical decision requiring prescriber sign-off.
4. If you are already a telehealth subscriber with a platform that includes pharmacy services, check whether finasteride is included in a bundled monthly fee, which some platforms offer at $30 to $60 per month covering both the consultation and the medication.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg at approximately $7 for a 30-day supply plus a small shipping fee and ships to Hawaii. [15] That platform requires a valid prescription and ships via USPS; transit time to Hawaii is typically 5 to 7 business days.

Are There Manufacturer Savings Programs for Finasteride in Hawaii?

Merck's branded Propecia savings card has historically reduced the out-of-pocket cost for commercially insured patients to as low as $25 to $30 per month, but savings cards generally do not apply to Medicaid or Medicare patients, and they do not help uninsured patients who pay full cash price. [16] Given that generic finasteride costs $12 or less per month in Hawaii, Merck's savings card is largely irrelevant for cash-paying patients.

Generic manufacturers do not typically offer branded savings cards. However, several patient assistance programs exist for low-income patients. NeedyMeds.org maintains a database of state and manufacturer programs searchable by drug name and zip code. [17] Hawaii-specific community health centers, including federally qualified health centers (FQHCs) such as Kokua Kalihi Valley and Waimanalo Health Center, may dispense medications at sliding-scale prices for qualified patients, and some stock finasteride in their in-house formularies.

The Hawaii Department of Health Pharmaceutical Assistance Program (HPAP) provides prescription cost assistance for certain low-income seniors and does not list finasteride as a covered drug under its current formulary. [8] That situation could change if BPH treatment guidelines push state programs to broaden 5-alpha-reductase inhibitor coverage, but as of the 2026 formulary review, finasteride remains excluded from HPAP.

Side Effects and Safety Monitoring for Hawaii Patients

Finasteride carries a black-box warning regarding its risk of high-grade prostate cancer based on data from the Prostate Cancer Prevention Trial (PCPT, N=18,882). [18] Men taking finasteride 5 mg showed a 24.8% relative reduction in prostate cancer prevalence but a higher proportion of high-grade tumors (Gleason score 7 to 10) in the finasteride arm (6.4% vs. 5.1%, P<0.001). [18] Subsequent analyses suggest this finding may reflect a detection artifact from the smaller prostate volume in the finasteride group, but the FDA label retains the warning. [2]

The FDA revised the finasteride label in 2012 to include sexual side effects that may persist after discontinuation. [2] Patients should be counseled that post-finasteride syndrome is an area of ongoing investigation. A 2023 systematic review in the Journal of Sexual Medicine identified persistent sexual dysfunction in a subset of patients but noted that the prevalence estimate varies widely (0.9% to 8%) across studies due to heterogeneous reporting methods. [19]

Baseline PSA testing is recommended for men over 40 before starting finasteride because finasteride reduces PSA by approximately 50%; a PSA result obtained while the patient is on finasteride should be doubled for interpretation purposes. [14] Hawaii's high rate of Asian and Pacific Islander men, who have different prostate cancer risk profiles than non-Hispanic white men, makes this baseline particularly relevant for local clinical practice.